Maxivision Group of Eye Hospitals has officially entered the Maharashtra market by forging a strategic alliance with Ojas Group of Eye Hospitals, a well-established eye care provider in Mumbai. This collaboration marks the formation of Ojas Maxivision Eye Hospitals, a joint venture set to invest ₹500 crores in expanding eye care services across the state.
The partnership was formally announced by Dr. GSK Velu, Promoter and Chairman of Maxivision Super Specialty Eye Hospitals, alongside Dr. Niteen Dedhia, Promoter and Chairman of Ojas Group of Eye Hospitals. The event also featured Dr. Rohan Dedhia, Promoter and Director of Ojas Group, Pranav Dedhia, CEO of Ojas Group, and VS Sudheer, Group CEO of Maxivision Super Specialty Eye Hospitals.
As per an official statement, the joint venture plans to establish five new centres across Mumbai within the next two years, with further expansion into other regions of Maharashtra.
Ojas Group of Eye Hospitals, under the leadership of Dr. Niteen Dedhia, currently operates three advanced centres in Mumbai—located in Bandra (W) and Kandivali (E). The group is known for offering cutting-edge eye treatments, including the flapless ELITA SILK vision correction procedure, 3D imaging and robotic-assisted cataract surgery, phakic lens implants for extreme refractive errors, and advanced treatments for dry eye syndrome.
Founded in 1996 by Dr. Kasu Prasad Reddy, Maxivision Super Specialty Eye Hospitals was later acquired by Dr. GSK Velu in 2011. Since then, the network has expanded to over 50 centres across six states—Telangana, Andhra Pradesh, Tamil Nadu, Kerala, Gujarat, and now, Maharashtra and Madhya Pradesh. Last year, Maxivision secured ₹1,300 crores in funding from Quadria Capital to accelerate both organic and inorganic growth, reinforcing its commitment to accessible and advanced eye care.
